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Summary
Notch signaling regulates cell fate decisions in a wide variety of adult and embryonic tissues. Here we show that Notch
pathway components and Notch target genes are upregulated in invasive pancreatic cancer, as well as in pancreatic
cancer precursors from both mouse and human. In mouse pancreas, ectopic Notch activation results in accumulation of
nestin-positive precursor cells and expansion of metaplastic ductal epithelium, previously identified as a precursor lesion
for pancreatic cancer. Notch is also activated as a direct consequence of EGF receptor activation in exocrine pancreas
and is required for TGF-induced changes in epithelial differentiation. These findings suggest that Notch mediates the
tumor-initiating effects of TGF by expanding a population of undifferentiated precursor cells.
Introduction tic of invasive pancreatic cancer, including ras activation and
accumulation of activated Erk, cyclin D, Cdk4, and nuclear p53
Pancreatic ductal adenocarcinoma represents the fifth leading (Wagner et al., 2001). A similar metaplasia/neoplasia sequence
cause of cancer death in Western populations and carries a has been observed in human pancreatic cancer (Parsa et al.,
five-year survival rate of less than 5% (Jemal et al., 2002). While 1985).
precursors of pancreatic cancer are less well characterized than We have previously demonstrated that TGF-induced aci-
in many other human neoplasms, recent studies have identified nar-to-ductal metaplasia involves expansion of undifferentiated
pancreatic intraepithelial neoplasia (PanIN) as a premalignant cell populations resembling those found in embryonic pancreas
lesion (Hruban et al., 1999). In transgenic mouse models, forma- (Song et al., 1999). During pancreatic development, differentia-
tion of PanIN-like lesions occurs in the context of a metaplasia/ tion of epithelial precursors is tightly regulated by Notch signal-
neoplasia sequence involving TGF-induced acinar-to-ductal ing, a highly conserved pathway known to regulate cell fate
metaplasia. On both a histologic and a molecular level, meta- decisions in a variety of organisms (Artavanis-Tsakonas et al.,
plastic epithelium arising under the influence of TGF has been 1999; Mumm and Kopan, 2000). In this context, Notch appears
identified as a direct precursor of malignant epithelium (Song to prevent cellular differentiation and maintain a population of
et al., 1999; Wagner et al., 1998, 2001). Histologically, direct undifferentiated precursor cells (Apelqvist et al., 1999; Jensen et
transitions between metaplastic and neoplastic epithelium have al., 2000a, 2000b). We have therefore analyzed Notch pathway
been demonstrated, with gradual progression frequently ob- activation in normal human pancreas, pancreatic cancer precur-
served in immediately contiguous areas of metaplastic epithe- sors, and invasive pancreatic ductal adenocarcinoma. In addi-
lium. It has also been demonstrated that, before the onset of tion, we have examined expression of Notch pathway compo-
dysplasia or cancer, metaplastic epithelium has already begun nents in premalignant epithelium and invasive pancreatic cancer
generated by transgenic overexpression of TGF in mouse pan-to progressively accumulate the molecular changes characteris-
S I G N I F I C A N C E
Pancreatic cancer is a highly lethal malignancy. Recent evidence has implicated overexpression of TGF in the pathogenesis of
this disease. In this report, we define Notch pathway activation as a direct consequence of EGF receptor signaling in exocrine
pancreas and demonstrate that Notch is a requisite downstream mediator of TGF-induced changes in epithelial differentiation.
These studies define a novel role for Notch in regulating metaplastic conversion between epithelial cell types and suggest an
important link between EGF receptor signaling and Notch pathway activation in the context of mammalian tumorigenesis. By
implicating Notch signaling in the very earliest phases of pancreatic cancer initiation, the current results provide new strategies for
early detection and chemoprevention.
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creas. Finally, we have determined the effects of ectopic Notch secreted frizzled-related protein 2, a known inhibitor of Wnt
signaling (Finch et al., 1997; Mayr et al., 1997).activation in explant cultures of normal mouse pancreas, as well
as the role of Notch in mediating TGF-induced changes in We further evaluated Notch pathway activation in human
pancreatic cancer using real-time quantitative RT-PCR analysisepithelial differentiation. These studies demonstrate a require-
ment for Notch pathway activation in the earliest stages of of ten additional infiltrating ductal adenocarcinomas of the pan-
creas and five specimens of normal pancreas. This analysispancreatic neoplasia and identify a requisite role for Notch in
mediating metaplastic conversion between differentiated cell confirmed upregulated expression of Notch ligands and recep-
tors in bulk tumor material. Relative expression values for thesetypes. In addition, this report defines a novel direct link between
EGF receptor signaling and Notch pathway activation in the components were similar to the values derived from microarray
analysis, with 3.4-fold overexpression of Notch2, 5.1-fold over-context of mammalian tumorigenesis, providing new strategies
for combinatorial chemoprevention. expression of Notch3, and 4.2-fold induction of jag1 observed
in tumor samples (Figure 1E). With respect to Notch target genes
(Hes1, Hes4, Hey1, and HeyL) assessed by real-time RT-PCR,Results
9 of 10 cancers expressed at least one target gene at a level
2-fold over normal, and 4 of 10 cancers expressed one targetExpression of Notch pathway components
in human pancreatic cancer gene at a level 3-fold over normal, confirming Notch pathway
activation in a majority of human pancreatic cancers. In orderBased on the known role of Notch signaling in regulating epithe-
lial differentiation in developing mouse pancreas (Apelqvist et to confirm this observation at the protein level, we analyzed
Hes1 by Western blot analysis of ten human pancreatic ductalal., 1999; Jensen et al., 2000a, 2000b), we examined expression
of Notch target genes in human pancreatic cancer and pancre- adenocarcinoma cell lines. We detected significant levels of
Hes1 protein in 6/10 pancreatic cancer cell lines, with high levelsatic cancer precursors. cRNA prepared from either normal pan-
creas (n  29) or pancreatic ductal adenocarcinoma (n  26) noted in four and lower levels in two (see Supplemental Fig-
ure S1 at http://www.cancercell.org/cgi/content/full/3/6/565/was hybridized to the complete Affymetrix Human Genome U95
GeneChip set (arrays U95 A-E). Within this set, 47 oligonucleo- DC1). Hes1 protein levels in the four high-expressing pancreatic
cancer cell lines were similar to those observed in associationtides covering 25 known genes were identified as components
of the classical Notch signaling pathway, defined as either Notch with previously documented Notch pathway activation in non-
small cell lung cancer lines (Chen et al., 1997).receptors (e.g., Notch2, Notch3; fragments corresponding to
Notch1 not present on these arrays), Notch ligands (e.g., delta, Further validation of upregulated Notch signaling in human
pancreatic cancer was obtained by immunohistochemical anal-jagged1), Notch target genes (e.g., Hes1, Hey1), or factors
known to regulate Notch pathway activity (e.g., presenilin-1, ysis involving 50 specimens of resected human pancreas.
Among these specimens, 34 were contained on tissue microar-sel1L). Genes from each of these categories were highly ex-
pressed in human pancreatic cancer, with several demonstra- rays, allowing for simultaneous staining of multiple specimens.
Immunohistochemical staining was performed using polyclonalting differential expression patterns in pancreatic cancer com-
pared to normal pancreas (Figure 1). Transcripts corresponding antibodies recognizing Notch1, Notch2, Notch3, Notch4, and
jagged2, while jagged1 expression was evaluated by in situto 25 fragments covering 17 Notch pathway components were
assessed to be “present” in at least 50% of either tumor or hybridization. For each of these Notch pathway components,
little-to-no expression was observed in normal pancreatic ductalnormal samples. Among these 25 fragments, 11 fragments cor-
responding to 9 different Notch pathway components were sig- epithelium (Figures 2A and 2C), and moderate-to-high level ex-
pression (defined as a score of 2 on a scale of 1–3) wasnificantly overexpressed in tumor tissue compared to normal
pancreas (Table 1). Notch receptors and ligands significantly never observed. In contrast, upregulated expression of Notch
receptors and ligands was frequently observed in resected pan-overexpressed in pancreatic cancer included Notch2, Notch3,
Notch4, dlk1, and jag1. With the exception of Notch3, which creatic cancer as well as PanIN lesions (Figures 2B and 2D–2G).
Among the four Notch receptors, moderate-to-high levels ofexhibited 5.8-fold overexpression in cancer specimens, the de-
gree of upregulated expression was moderate, typically in the detectable protein were observed as follows: Notch1, 16 of 34
specimens; Notch2, 16 of 34; Notch3, 12 of 33; and Notch4,range of 2- to 3-fold. In contrast, the human ortholog of C.
elegans sel-1 (sel1L), a known inhibitor of Notch pathway activa- 15 of 33. Expression of different Notch family members tended
to be concordant within individual tumor specimens (see Sup-tion, was downregulated in cancer versus normal, consistent
with previous observations regarding downregulation of this plemental Table S1 on the Cancer Cell website). Among all
examined specimens, 21 of 34 (62%) showed moderate-to-highgene in human pancreatic adenocarcinoma cell lines (Donoviel
et al., 1998; Grant and Greenwald, 1997; Harada et al., 1999). level expression of at least one Notch protein. Similarly, tumor
sections frequently contained moderate-to-high levels of jag-Evidence that relative overexpression of Notch receptors and
ligands resulted in functionally significant changes in Notch ged2 protein (11 of 33 by immunohistochemistry) and jagged1
RNA (21/33 scored as positive by in situ hybridization). As withpathway activation was provided by associated upregulation of
several known and candidate Notch target genes, including the four Notch receptors, jagged1 and jagged2 expression
tended to be concordant within individual tumor specimens;Hes1, Hes4, Hey1, and HeyL (Davis and Turner, 2001; Iso et
al., 2001). Together, these data suggest activation of a Notch among the 12 tumors lacking jagged1, only one expressed jag-
ged2 protein at moderate-to-high levels.signaling “module” in human pancreatic adenocarcinoma. In
contrast, expression profiling of Wnt pathway components re- These data confirm upregulated expression of Notch recep-
tors and ligands in human pancreatic cancer. However, upregu-vealed no similar tendency for modular upregulation of activat-
ing elements (Figure 1D); the Wnt pathway component with lated expression of receptors and ligands does not necessarily
imply functional pathway activation. In order to specifically de-the highest level of overexpression in pancreatic cancer was
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Figure 1. Modular upregulation of Notch path-
way components in pancreatic ductal adeno-
carcinoma
A: Normalized hybridization intensities for 8,863
gene fragments included on Affymetrix U95A
GeneChip. Data represent mean values from 26
pancreatic ductal cancers and 29 specimens of
normal pancreas. Values distribute symmetri-
cally about line of unity, with multiple fragments
either overexpressed or underexpressed in can-
cer versus normal.
B: Expression values for 25 gene fragments repre-
senting 17 different Notch pathway compo-
nents; fragments corresponding to Notch1 are
not present on these arrays. Note moderate
overexpression of Notch3, Hes4, and HeyL, as
well as relative underexpression of sel-1L.
C: Expanded view of shaded area in panel B
allowing examination of expression values for
Notch pathway components with lower hybrid-
ization intensities. Note moderate overexpression
of Notch2, jag1, dlk1, Hes1, and Hey1.
D: Expression values for 40 gene fragments repre-
senting 28 different Wnt pathway components.
Gene fragments with highest degree of overex-
pression in cancer versus normal correspond to
sFRP2 (secreted frizzled-related protein 2), a
known inhibitor of Wnt signaling.
E: Real-time RT-PCR analysis demonstrating rela-
tive expression levels of Notch receptors and li-
gands in ten additional resected cancers and
five specimens of normal pancreas. N, normal
pancreas; Tu, tumor.
termine the functional status of Notch signaling in normal and lesions and invasive pancreatic cancer (Figure 2J–2L). Com-
pared to normal interlobular ductal epithelium, there was a 15-neoplastic human pancreas, immunohistochemical analysis of
Hes1 protein was performed on a total of 33 resected speci- fold increase in frequency of Hes1-positive cells in metaplastic
duct lesions, a 5-fold increase in PanIN lesions, and a 7-foldmens, of which 17 were contained within tissue microarrays.
increase in epithelial cells of infiltrating ductal adenocarcinomaExamination of nonpancreatic tissues revealed high levels of
(p  0.01 for metaplastic epithelium versus normal, p  0.06nuclear Hes1 protein in basal epithelial cells of normal prostate
for PanIN versus normal, p  0.01 for cancer versus normal).and in crypt cells of normal colon (data not shown), consistent
with Notch pathway activation in known epithelial precursor
populations. Hes1 protein expression in normal human pan- Ectopic Notch pathway activation in normal pancreas
The frequent expression of Hes1 in metaplastic duct lesionscreas was infrequent and largely confined to centroacinar cells
and terminal ductal epithelium (Figure 2H), consistent with a and PanIN epithelium suggested that Notch pathway activation
might occur as an early event in pancreatic tumorigenesis. Wepossible precursor function for these cell populations (Gas-
slander et al., 1992; Hayashi et al., 1999). Normal interlobular therefore examined the effects of ectopic Notch activation in
normal pancreatic tissue using an explant culture system. Colla-ductal epithelium showed occasional low-level Hes1 expres-
sion, typically involving only a very small number of epithelial gen-digested mouse pancreas was depleted of stromal ele-
ments, large ductal structures, and pancreatic islets, resultingcells (Figure 2I). Hes1 protein expression was significantly ex-
panded in metaplastic ductal epithelium as well as in PanIN in epithelial explants predominantly comprised of acinar cells,
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Table 1. Expression values for 25 cDNA fragments covering 17 known Notch pathway components in pancreatic cancer and normal pancreas
Fold difference
Fragment name Known gene name (cancer versus normal) t test
52819_at delta-like 4 homolog (Drosophila) 0.9 NS
32648_at delta-like homolog (Drosophila) 2.4 0.01
37393_at hairy (Drosophila)-homolog (Hes1) 1.9 0.0001
44783_s_at hairy/enhancer-of-split related with YRPW motif 1 1.8 0.001
46813_at hairy/enhancer-of-split related with YRPW motif 2 1.4 NS
79699_at hairy/enhancer-of-split related with YRPW motif 2 1.1 NS
43489_at hairy/enhancer-of-split related with YRPW motif-like 2.9 0.0001
54852_at hairy/enhancer-of-split related with YRPW motif-like 1.8 0.03
77244_at Hes4 2.3 0.0001
35414_s_at jagged1 (Alagille syndrome) 2.0 0.0001
33178_at jagged1 (Alagille syndrome) 1.1 NS
74827_s_at jagged1 (Alagille syndrome) 3.0 0.0003
32137_at jagged2 1.3 NS
48486_at Notch (Drosophila) homolog 2 2.6 0.0006
38750_at Notch (Drosophila) homolog 3 5.8 0.0001
39048_at Notch (Drosophila) homolog 4 1.7 0.002
37693_at numb (Drosophila) homolog 1.0 NS
641_at presenilin 1 (Alzheimer disease 3) 1.0 NS
642_s_at presenilin 1 (Alzheimer disease 3) 1.1 NS
40689_at sel-1 (suppressor of lin-12, C. elegans)-like 0.6 NS
65740_at sel-1 (suppressor of lin-12, C. elegans)-like 0.6 0.03
76761_at sel-1 (suppressor of lin-12, C. elegans)-like 0.6 NS
41489_at transducin-like enhancer of split 1, homolog of Drosophila E(sp1) 1.3 NS
56754_at transducin-like enhancer of split 1, homolog of Drosophila E(sp1) 1.4 NS
40837_at transducin-like enhancer of split 2, homolog of Drosophila E(sp1) 0.8 NS
Fragments corresponding to Notch1 are not present on utilized arrays.
centroacinar cells, and associated terminal ductal epithelium. acinar-to-ductal metaplasia appeared to proceed through an
undifferentiated intermediate characterized by upregulated ex-Epithelial explants were infected with previously characterized
adenoviral vectors encoding either GFP (Ad-GFP) or GFP plus pression of nestin (Figures 3M–3O), an intermediate filament
expressed by precursor cell types in pancreas and CNS (Kawa-the activated intracellular domain of either Notch1 (Ad-GFP/
Notch1-IC) or Notch2 (Ad-GFP/Notch2-IC) (Sriuranpong et al., guchi et al., 2001; Messam et al., 2000; Zulewski et al., 2001).
These data suggest that Notch activation results in expansion2001). In addition, direct expression of Notch target genes was
accomplished using adenoviral vectors encoding GFP plus ei- of an undifferentiated precursor population in exocrine pan-
creas. In this regard, the effects of ectopic Notch activationther Hes1 (Ad-GFP/Hes1), Hey1 (Ad-GFP/Hey1), or Hey2 (Ad-
GFP/Hey2). High-efficiency gene delivery was confirmed by appeared identical to those previously reported for TGF (Song
et al., 1999; Wagner et al., 2002). Adenovirus-mediated overex-GFP visualization as well as by RT-PCR, confirming successful
expression of Notch1-IC and/or induced target genes at 2 and pression of several known Notch target genes, including Hes1,
Hey1, and Hey2, failed to recapitulate the effects of activated4 days following infection (Figures 3A–3C). As shown in Figure
3C, adenoviral delivery of Notch1-IC resulted in upregulated Notch (data not shown), suggesting a requirement for combina-
tions of target genes and/or additional downstream effectors.Hes1 expression at levels similar to those achieved following
Ad-GFP/Hes1 infection, while Hey1 and Hey2 were induced at
lower levels. Previous studies have suggested significant cell Transgenic overexpression of TGF activates Notch
type specificity in the relative responsiveness of Hes1, Hey1, signaling in exocrine pancreas
and Hey2 to induction by Notch (Iso et al., 2001, 2002); these Based on the striking similarity between Notch-mediated acinar-
data define each of these as Notch-responsive elements in to-ductal metaplasia and events induced by TGF, we next
mouse pancreas. determined the role of Notch signaling as a possible mediator
During the five day culture period, Ad-GFP-infected epithe- of EGF receptor activation in mouse pancreas, using both in
lium behaved in a manner identical to that observed for unin- vivo and in vitro systems. Transgenic overexpression of TGF
fected control epithelium, with a predominant acinar cell popula- driven by either an elastase-1 promoter (Ela-TGF) or a zinc-
tion persisting until loss of explant viability (Figure 3D). In inducible metallothionein promoter (MT-TGF) results in initia-
contrast, explants infected with either Ad-GFP/Notch1-IC or tion of a metaplasia/neoplasia sequence characterized by dra-
Ad-GFP/Notch2-IC underwent metaplastic conversion from an matic changes in epithelial differentiation including loss of acinar
cell mass, expansion of Pdx1-positive precursors, acinar-to-acinar cell-predominant epithelium to a ductal cell-predominant
epithelium. This process involved conversion from acinar to ductal metaplasia, and formation of PanIN-like lesions. When
placed on a p53/background, these precursors show acceler-ductal morphology (Figures 3E and 3F), gradual loss of acinar
cell-specific gene expression (Figures 3G–3I), and acquired ex- ated progression to invasive pancreatic cancer (Jhappan et al.,
1990; Sandgren et al., 1990; Song et al., 1999; Wagner et al.,pression of ductal markers including carbonic anhydrase (data
not shown) and cytokeratin-20 (Figures 3J–3L). Notch-mediated 1998, 2001). We therefore evaluated expression of Notch path-
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Figure 2. Expression of Notch pathway components in invasive pancreatic cancer and pancreatic cancer precursors
A and B: (400), Detection of jagged1 transcripts by in situ hybridization in normal intralobular ductal epithelium (A) and invasive pancreatic cancer (B).
Arrows in (B) indicate punctate staining indicative of jagged1 expression.
C and D: (400), Immunohistochemical detection of Jagged2 in normal interlobular ductal epithelium (C) and invasive pancreatic cancer (D).
E: Immunohistochemical detection of Notch1 protein in PanIN2 epithelium (400).
F and G: Immunohistochemical detection of upregulated Notch1 (F) and Notch2 (G) expression in invasive pancreatic cancer. Arrow in (F) indicates
absence of Notch1 protein in adjacent normal ductal epithelium.
H–L: Immunohistochemical detection of nuclear Hes1 protein in human pancreatic tissue. H: Normal exocrine pancreas (100); arrows indicate Hes1-
positive centroacinar cells. Inset (400) shows single acinar unit with Hes1-positive centroacinar cell (arrowhead). I: Normal interlobular pancreatic ductal
epithelium (400); arrow indicates low-frequency Hes1-positive duct cells. J: Hes1-positive metaplastic ductal epithelium in area of chronic pancreatitis
(20). K: High-level Hes1 expression in PanIN 2 epithelium (400). L: Nuclear Hes1 immunoreactivity in invasive pancreatic ductal adenocarcinoma with
perineural infiltration (100).
way components in pancreatic tissue from both Ela-TGF and tic epithelium (Figures 4E and 4G) and in centroacinar cells
(Figure 4F). Similar to the pattern previously reported for Pdx1MT-TGF transgenic mice at different steps along this metapla-
expression in these lesions (Song et al., 1999), abrupt transitionssia/neoplasia progression, using both real-time quantitative
were observed between Hes1-positive metaplastic epitheliumPCR and immunohistochemistry. Pancreatic tissue from 24-
and adjacent Hes1-negative acinar cells (see arrowheads inweek Ela-TGF mice frequently demonstrated upregulated ex-
Figure 4G). These results demonstrate that transgenic overex-pression of Notch ligands, receptors, and target genes relative
pression of TGF in mouse pancreas results in Notch pathwayto normal mouse pancreas, as assessed by real-time RT-PCR
activation in pancreatic cancer precursors. In addition, the docu-(Figure 4A). These elevated expression levels were generally
mentation of both Hes1 and Pdx1 expression in premalignantmaintained without additional increases in pancreatic tumor ma-
metaplastic epithelium further emphasizes the similarity be-terial from Ela-TGF;p53/ mice. Expression levels of certain
tween this epithelium and the undifferentiated epithelium of thegenes (e.g., Hes1) returned to normal in tumor material, sug-
developing pancreas.gesting a role in early precursors but not necessarily in invasive
cancer. Further evaluation of Notch activity in premalignant epi-
thelium from TGF transgenic pancreas was performed using TGF-induced Notch activation is required for initiation
immunohistochemistry for Notch1 and Hes1. As in the case of of the metaplasia/neoplasia sequence
normal human pancreas, pancreatic tissue from nontransgenic In order to clarify the functional significance of TGF-induced
littermates demonstrated little-to-no expression of either of Notch activation in exocrine pancreas, we further evaluated
these proteins (Figures 4B and 4D). In contrast, metaplastic duct the relationship between these signaling pathways in epithelial
lesions and low-grade PanIN lesions demonstrated frequent explants. We have recently demonstrated that explant cultures
expression of Notch1 (Figure 4C). Similarly, a striking pattern of of pancreatic tissue from transgenic mice overexpressing TGF
Hes1 protein expression was observed, with high-level nuclear spontaneously initiate the metaplasia/neoplasia sequence, and
that this effect can be induced in explant cultures of normalexpression observed in TGF-induced premalignant metaplas-
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TGF-treated explants demonstrated accumulation of tran-
scripts for both Hes1 and Hey1, coincident with initiation and
progression of acinar-to-ductal metaplasia. In contrast, no acti-
vation of Hey2 was observed during this process (data not
shown). These data suggest that TGF activates Notch signaling
during initiation of the metaplasia/neoplasia sequence in vitro,
similar to the in vivo activation observed in TGF transgenic
mice.
Further evidence of Notch pathway activation during
TGF-induced acinar-to-ductal metaplasia was provided by ex-
amining the acetylation status of histone proteins associated
with cis-acting elements in the Hes1 promoter. In the absence
of Notch-IC, RBP-J	 functions as a transcriptional repressor in
complex with SMRT and the histone deacetylase, HDAC-1. In
this setting, histone proteins associated with RBP-J	-regulated
transcriptional units are characterized by low acetylation levels.
Transcriptional activation of Notch target genes involves disrup-
tion of the RBP-J	/SMRT/HDAC-1 corepressor complex in favor
of a complex involving RBP-J	 and Notch-IC, resulting in his-
tone acetylation and conversion of RBP-J	 from a transcrip-
tional repressor to a transcriptional activator (Kao et al., 1998).
We therefore examined the acetylation status of histone proteins
associated with cis-acting elements in the Hes1 promoter using
chromatin immunoprecipitation (ChIP) assays. Following cross-
linking and immunoprecipitation of cellular lysates using anti-
bodies recognizing either acetylated histone H3 or acetylated
histone H4, we utilized semiquantitative PCR to determine the
amount of associated genomic DNA corresponding to a 545 bp
element spanning an RBP-J	 binding site in the Hes1 promoter.
Initial assay validation confirmed a Notch-dependent increase
in Hes1 promoter-associated acetylated histone H3 (but not
histone H4) in cultured pancreatic acinar cells (Figure 5B). An
identical increase in Hes1 promoter-associated acetylated his-
tone H3 was achieved by treatment of pancreatic acinar cells
with trichostatin A (TSA), an inhibitor of HDAC previously shown
to potentiate expression of Notch target genes in Xenopus ani-Figure 3. Acinar-to-ductal metaplasia induced by ectopic Notch activation
mal caps (Kao et al., 1998). In cellular lysates prepared fromin pancreatic explants
explant cultures of mouse pancreas treated with and withoutA and B: Corresponding phase-contrast (A) and fluorescent (B) images
demonstrating high-efficiency expression of GFP in pancreatic explants 24 TGF, a consistent 4-fold increase in Hes1 promoter-associated
hr after infection with Ad-GFP (400). Similar levels of GFP expression were acetylated histone H3 was observed following treatment with
obtained for all adenoviral vectors. TGF (Figure 5C). These data demonstrate that TGF-induced
C: RT-PCR analysis of Notch1 and Notch target gene expression at 2 and
acinar-to-ductal metaplasia is associated with changes in Hes14 days following infection with Ad-GFP, Ad-GFP/Notch1-IC (N1), Ad-GFP/
promoter-associated histone H3 acetylation identical to thoseHes1, Ad-GFP/Hey1, and Ad-GFP/Hey2.
D: Low-frequency of acinar-to-ductal metaplasia in pancreatic explants 5 induced by Notch or by pharmacologic inhibition of HDAC.
days after infection with Ad-GFP (20). To further determine whether TGF-induced upregulation
E (20) and F (100): High-frequency acinar-to-ductal metaplasia in pan- of Hes1 and Hey1 was mediated by classical Notch pathwaycreatic explant 5 days after infection with Ad-GFP/Notch1-IC.
activation, we utilized pharmacologic inhibitors of 
-secretase,G–O: (100), Immunofluorescent analysis of amylase (G–I), cytokeratin 20
(J–L), and nestin (M–O) expression on day 0 (G, J, and M), day 3 (H, K, and an intramembrane protease known to be required for activating
N), and day 5 (I, L, and O) following infection of pancreatic explants with cleavage of Notch receptors following ligand binding (Berezov-
Ad-GFP/Notch1-IC. ska et al., 2000; De Strooper et al., 1999). Compound 1, a
previously characterized peptidomimetic inhibitor of 
-secre-
tase (Wolfe et al., 1999), eliminated induction of both Hes1
and Hey1 following treatment of pancreatic explants with TGFpancreas by treatment with soluble recombinant TGF (Wagner
(Figure 5D). Similarly, this compound effectively downregulatedet al., 2002). We therefore treated explant cultures of normal
Hes1 protein levels in BXPC3 human pancreatic cancer cellsmouse pancreas with and without TGF and evaluated expres-
(data not shown). In both BXPC3 cells and mouse pancreaticsion of endogenous Notch target genes by semiquantitative RT-
explants, the IC50 for downregulation of Hes1 expression byPCR (Figure 5A). Prior to the onset of TGF-induced acinar-to-
compound 1 was 30 M, consistent with previous reportsductal metaplasia, transcripts for Hes1 and Hey1 were minimally
regarding inhibition of Notch1-IC generation in CHO cells (Be-detectable following 25 cycles of PCR amplification. Increased
rezovska et al., 2000). These findings suggest that Hes1 expres-expression of these Notch target genes was never observed in
untreated explant cultures over a five day time course. sion in human pancreatic cancer cell lines and TGF-induced
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Figure 4. Transgenic overexpression of TGF results in Notch pathway activation in premalignant pancreatic epithelium and malignant pancreatic cancer
A: Real-time RT-PCR analysis demonstrating relative expression of Notch receptors, ligands, and target genes in normal mouse pancreas (N), metaplastic
Ela-TGF mouse pancreas (M), and invasive tumors from Ela-TGF;p53/ mouse pancreas (Tu).
B: Absence of immunohistochemically detectable Notch1 protein in normal pancreatic ductal epithelium from nontransgenic littermate control (100).
C: Upregulated Notch1 protein in premalignant metaplastic epithelium from MT-TGF transgenic mouse pancreas (100).
D: Absence of immunohistochemically detectable Hes1 protein in normal pancreatic ductal epithelium from nontransgenic littermate control (400).
E: Detection of nuclear Hes1 protein in premalignant metaplastic epithelium from MT-TGF mouse pancreas. Arrows indicate absence of Hes1 protein in
adjacent normal acini (100).
F: Nuclear Hes1 protein in metaplastic epithelium as well as centroacinar cells (arrow) from MT-TGF mouse pancreas (400).
G: Abrupt transition (arrows) between Hes1-positive metaplastic epithelium and Hes1-negative acinar cells (400).
Hes1 expression in mouse pancreatic explants are both medi- GPF/Notch1-IC, encoding a “pre-cleaved” Notch1 intracellular
domain not requiring 
-secretase-mediated proteolytic activa-ated by classical 
-secretase-dependent Notch pathway activa-
tion. tion. Ad-GFP/Notch1-IC remained fully capable of “rescuing”
acinar-to-ductal metaplasia in compound 1-treated explants,To determine whether Notch pathway activation was re-
quired for TGF-mediated changes in epithelial differentiation, even at compound 1 concentrations associated with effective
inhibition of the TGF effect (Figure 7). These findings confirmwe examined the effects of compound 1 and three additional
peptidomimetic inhibitors of 
-secretase on TGF-induced aci- that the effects of 
-secretase inhibition in this system were
specifically due to a deficit in generation of activated Notch.nar-to-ductal metaplasia. In explant cultures of normal mouse
pancreas, compound 1 effectively prevented acinar-to-ductal Thus, TGF not only induces 
-secretase-dependent Notch ac-
tivation in pancreatic epithelial explants, but this activation ofmetaplasia at concentrations identical to those required for
downregulation of TGF-induced Hes1 activation (Figure 6). Notch is also required for TGF-induced initiation of pancreatic
epithelial metaplasia. Further insights regarding functional inter-In addition, this compound effectively inhibited spontaneous
initiation of the metaplasia/neoplasia sequence in explant cul- actions between Notch and EGF receptor signaling in the induc-
tion of pancreatic epithelial metaplasia were provided by evalu-tures of MT-TGF pancreas. Dose-dependent effects were also
observed for compound 11, WPE-III-31C, and DAPT. In con- ating the effects of AG1478, a specific inhibitor of EGF receptor
tyrosine kinase activity. At low micromolar concentrations,trast, a stereoisomer of compound 11 containing a D-valine
residue had no effect, minimizing the possibility that the ob- AG1478 completely abolished induction of acinar-to-ductal
metaplasia by TGF, but had little-to-no effect on changes inserved effects of 
-secretase inhibition in this system were me-
diated through nonspecific cellular toxicity. Further confirmation epithelial differentiation induced by Ad-GFP/Notch1-IC (Figure
7). Notch pathway activation is therefore capable of bypassingthat the effect of 
-secretase inhibition was specifically medi-
ated by a disruption in Notch signaling was achieved using Ad- a requirement for EGF receptor signaling in the induction of
CANCER CELL : JUNE 2003 571
A R T I C L E
In developing pancreas and other foregut derivatives, Notch
signaling inhibits early commitment of epithelial progenitors to
an endocrine lineage, apparently by suppressing expression of
ngn3 and neuroD/2 (Apelqvist et al., 1999; Jensen et al., 2000a,
2000b). Targeted deletion of Notch pathway components re-
sults in precocious endocrine differentiation, depletion of epithe-
lial progenitors, and failure to differentiate normal exocrine lin-
eages. Although these previous studies demonstrate that Notch
pathway activation is required to reserve a population of exo-
crine precursors during early pancreatic development, our data
suggest that Notch signaling is silenced in mature exocrine
pancreas and that ectopic reactivation of Notch results in loss
of acinar cell differentiation. As in other cellular contexts, Notch
target genes may actively repress expression of lineage-speci-
fying transcription factors in exocrine pancreas. In this regard,
our demonstration of nestin-positive intermediates during
Notch-induced acinar-to-ductal metaplasia suggests that Hes1
and/or Hey1 may actively repress expression of transcription
factors required for maintenance of acinar cell differentiation,
Figure 5. TGF induces Notch pathway activation during acinar-to-ductal resulting in expansion of a dedifferentiated nestin-positive pop-
metaplasia in explant cultures of normal mouse pancreas ulation and initiation of the metaplasia/neoplasia sequence.
A: Semiquantitative RT-PCR analysis demonstrating activation of endoge- While the role of nestin-positive epithelial precursors in develop-
nous Notch target genes during TGF-induced acinar-to-ductal metaplasia. ing pancreas remains controversial (Hunziker and Stein, 2000;
B: Pre-IP material and ChIP assay for Hes1 promoter-associated acetylated
Lechner et al., 2002; Selander and Edlund, 2002; Zulewski ethistone H3 following treatment of 266-6 cells with either TSA or Ad-GFP/
al., 2001), our finding of Notch-induced expansion of nestin-Notch1-IC. Pre-IP material demonstrates equal amounts of input Hes1 geno-
mic DNA in TSA versus control and Ad-GFP/Notch1-IC versus Ad-GFP condi- positive intermediates is consistent with previous reports dem-
tions. Both TSA and Ad-GFP/Notch1-IC increase Hes1 promoter-associated onstrating an association between Notch signaling and mainte-
acetylated histone H3. nance of nestin-positive precursors in developing mouse brainC: Pre-IP material and ChIP assay for Hes1 promoter-associated acetylated
(Irvin et al., 2001; Lutolf et al., 2002).histone H3 following treatment of mouse pancreatic explants with and
Based on the requirement for Notch pathway activation inwithout TGF. TGF-treated explants demonstrate an increase in Hes1 pro-
moter-associated acetylated histone H3. mediating the effects of TGF, the current data demonstrate a
D: Semiquantitative RT-PCR analysis demonstrating effective inhibition of direct relationship between EGF receptor activation and Notch
TGF-mediated Hes1 activation by increasing concentrations of com-
signaling in the generation of pancreatic cancer precursors.pound 1.
There is significant precedent for crosstalk between EGF and
Notch signaling in a number of developmental systems, with
both cooperative and antagonistic interactions previously re-
ported (Price et al., 1997; zur Lage and Jarman, 1999). However,acinar-to-ductal metaplasia. Together with documented Notch
interactions between Notch and EGF receptor signaling havepathway activation following transgenic overexpression of
not been previously reported in the context of mammalian neo-TGF, these results demonstrate that Notch pathway activation
plasia. Based on the role of ras in mediating certain aspects ofrepresents a required downstream mediator of EGF receptor
EGF receptor signaling, it is interesting to consider interactionssignaling in exocrine pancreas.
between ras signaling and Notch pathway activation during
pancreatic tumorigenesis. Reciprocal interactions between rasDiscussion
and Notch have been described during vulval development in
C. elegans (Berset et al., 2001) and during retinal, mesodermal,The current results demonstrate activation of Notch signaling
and peripheral nervous system development in Drosophila (Car-as an extremely early event in pancreatic tumorigenesis and
mena et al., 2002; Culi et al., 2001; Tomlinson and Struhl, 2001).further suggest that Notch pathway activation is a required
In mammalian cells, activated forms of both Notch1 and Notch2downstream mediator of EGF receptor activity in the pathogene-
are capable of substituting for activated ras in cooperative trans-sis of this disease. As a surrogate marker of Notch activity,
formation assays (Capobianco et al., 1997), and interactionsHes1 protein was identified not only in invasive pancreatic ductal
between ras signaling and Notch are required for maintenanceadenocarcinomas, but also in metaplastic and neoplastic pan-
of the malignant phenotype induced by activated Notch4 ex-creatic cancer precursors in both mouse and human. The asso-
pression in mouse mammary epithelium (Fitzgerald et al., 2000).ciation of Notch with early events in a metaplasia/neoplasia
Additional evidence suggests that Notch is required for initiationsequence is further supported by the finding that ectopic Notch
and maintenance of the malignant phenotype in ras-transformedactivation induces acinar-to-ductal metaplasia in explant cul-
cells and that oncogenic ras is capable of activating Notchtures of normal mouse pancreas, and that Notch is required for
signaling, apparently by increasing expression of Notch1,mediation of TGF-induced changes in epithelial differentiation.
Delta1, and presenilin-1 (Ruiz-Hidalgo et al., 1999; Weijzen etFuture study will determine whether these effects are unique
al., 2002). Based upon previously documented ras pathwayto pancreas, or whether Notch signaling represents a general
activation in pancreatic tissue from transgenic mice overex-mechanism for initiating metaplastic conversion between epi-
thelial cell types during mammalian tumorigenesis. pressing TGF (Wagner et al., 2001), as well as the high rate of
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Figure 6. Requirement for Notch signaling in
TGF-mediated acinar-to-ductal metaplasia
Graphs demonstrate effect of four different

-secretase inhibitors (compound 11, com-
pound 1, WPE-III-31C, and DAPT) as well as inac-
tive stereoisomer (compound 12) on TGF-
induced acinar-to-ductal metaplasia. Black bars
indicate effect of active inhibitors, gray bars indi-
cate effect of compound 12.
Figure 7. Functional interactions between EGF
and Notch signaling during TGF-mediated aci-
nar-to-ductal metaplasia
The EGF receptor tyrosine kinase inhibitor
AG1478 eliminates both basal and TGF-
induced acinar-to-ductal metaplasia, but has
minimal effect on acinar-to-ductal metaplasia
induced by Ad-GFP/Notch1-IC. The 
-secretase
inhibitor compound 1 effectively prevents TGF-
induced acinar-to-ductal metaplasia, but has
no effect on acinar-to-ductal metaplasia in-
duced by Ad-GFP/Notch1-IC.
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Ectopic Notch pathway activation in pancreatic explantsactivating ras mutations observed in human pancreatic cancer
Explant cultures of collagenase-digested mouse pancreas were prepared(Hruban et al., 1999), this relationship may contribute to the
as previously described (Wagner et al., 2002) and infected with previouslyupregulated expression of Notch receptors and ligands ob-
characterized recombinant adenoviral vectors encoding either GFP alone or
served in the current study. GFP with Notch1-IC, Notch2-IC, or Hes1 (Sriuranpong et al., 2001). In addi-
In combination with the recent identification of acinar-to- tion, adenoviral vectors encoding N-terminal Flag epitope-tagged Hey1 and
ductal metaplasia and PanIN formation as precursor lesions for Hey2 were generated in a pShuttle backbone using previously established
pancreatic ductal adenocarcinoma (Hruban et al., 1999; Wagner techniques (He et al., 1998). All infections were performed at an MOI of
20:1 for 1 hr at 37C. Confirmation of successful viral transduction waset al., 1998, 2001), the current data provide an opportunity to
accomplished by examination of high-efficiency GFP expression as well asgenerate a unifying model for pancreatic tumorigenesis. We
RT-PCR for encoded cDNA’s and Notch target genes.propose that augmented EGF receptor activity represents an
initiating event (Korc, 1998; Wagner et al., 2001), resulting in
Evaluation of endogenous Notch pathway activation
Notch pathway activation in exocrine tissue. Notch activation in TGF-treated explants
induces dedifferentiation of mature exocrine cells and expan- Acinar-to-ductal metaplasia was induced in explant cultures of normal
sion of metaplastic ductal epithelium sharing features with em- mouse pancreas by daily treatment with recombinant human TGF (50 ng/ml;
bryonic pancreas (Song et al., 1999). These Notch-mediated R&D Systems). Endogenous Notch pathway activation was determined by
semiquantitative RT-PCR for Hes1, Hey1, and Hey2. To evaluate TGF-changes in epithelial differentiation promote formation of early
induced changes in histone acetylation in association with Hes1 promoterPanIN lesions, arising in either metaplastic or preexisting ductal
elements, chromatin immunoprecipitation (ChIP) assays were performedepithelium. Once formed, PanIN lesions undergo progressive
using Acetyl-Histone H3 and Acetyl-Histone H4 Immunoprecipitation Assayaccumulation of well-characterized genetic changes (Moskaluk
Kits (Upstate Biotechnology) according to manufacturer’s recommenda-
et al., 1997; Wilentz et al., 2000), ultimately resulting in invasive tions. Hes1 promoter sequences in complex with acetylated histones were
ductal cancer. In addition to altering epithelial differentiation to amplified with PCR primers chosen to specifically amplify genomic DNA
promote generation of precursor lesions, Notch may also pro- flanking a highly conserved RBP-J	 binding site in the Hes1 promoter.
vide an ongoing growth advantage to malignant epithelium,
Notch pathway inhibitionreflected by maintenance of an active Notch pathway in invasive
Endogenous Notch pathway inhibition was achieved using the followingpancreatic cancer. In this regard, Notch signaling has previously
peptidomimetic inhibitors of 
-secretase: compound 1 (DFK-167; Enzymebeen associated with activation of NF-kappaB (Bellavia et al.,
Systems Products, Livermore, California), compound 11 (Wolfe et al., 1999),
2000; Cheng et al., 2001; Nickoloff et al., 2002; Oswald et al.,
WPE-III-31C (Esler et al., 2002), and DAPT (Dovey et al., 2001). Control
1998) and enhanced expression of bcl-2 and cyclin D1 (Deftos explants were treated with either DMSO vehicle or with compound 12, an
and Bevan, 2000; Ronchini and Capobianco, 2001), factors inactive stereoisomer of compound 11 (Wolfe et al., 1999). Compounds 11
which potentially contribute to the malignant phenotype of hu- and 12, WPE-III-31C, and DAPT were synthesized as previously described
and assessed for purity by 1H NMR (300 MHz), mass spectrometry (MALDI-man pancreatic cancer (Arlt et al., 2001; Gansauge et al., 1997;
TOF), and elemental analysis (Desert Analytics, Tucson, Arizona).Hu et al., 1999).
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